Adage Capital Partners’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.1M | Sell |
3,890,177
-1,309,823
| -25% | -$12.2M | 0.06% | 306 |
|
|
2025
Q1 | $38.1M | Buy |
5,200,000
+1,600,000
| +44% | +$11.7M | 0.07% | 288 |
|
|
2024
Q4 | $30.7M | Sell |
3,600,000
-150,000
| -4% | -$1.28M | 0.05% | 320 |
|
|
2024
Q3 | $32.6M | Buy |
3,750,000
+54,953
| +1% | +$478K | 0.06% | 318 |
|
|
2024
Q2 | $25.3M | Buy |
3,695,047
+3,320,047
| +885% | +$22.7M | 0.05% | 376 |
|
|
2024
Q1 | $3.41M | Buy |
+375,000
| New | +$3.41M | 0.01% | 735 |
|